You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models

Article metrics

Article menu

This article has a correction. Please see:

XML
Oncolytic and local immunotherapy
Original research
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models

 

Online download statistics by month:

Online download statistics by month: July 2021 to December 2025

AbstractFullPdf
Jul 2021524530234
Aug 2021394395176
Sep 202120120191
Oct 202116916990
Nov 202116115971
Dec 202110811136
Jan 20229610446
Feb 202210511055
Mar 202217018258
Apr 202213414358
May 202211112081
Jun 202211213069
Jul 2022799442
Aug 20229811565
Sep 20229710184
Oct 2022919963
Nov 2022717550
Dec 2022959740
Jan 2023798242
Feb 202313713851
Mar 2023757663
Apr 2023686939
May 2023626440
Jun 2023565648
Jul 2023464735
Aug 2023596043
Sep 2023545537
Oct 2023575735
Nov 2023495132
Dec 2023535723
Jan 2024596034
Feb 2024585821
Mar 2024555648
Apr 2024495440
May 2024525331
Jun 202411411441
Jul 2024646529
Aug 2024505235
Sep 2024575728
Oct 2024575736
Nov 2024404127
Dec 2024778548
Jan 2025879151
Feb 2025525228
Mar 2025636642
Apr 20259910058
May 2025808280
Jun 2025525221
Jul 2025110
Dec 2025100
Total477849432595